271 related articles for article (PubMed ID: 12745416)
1. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
Beswick T; Best D; Rees S; Bearn J; Gossop M; Strang J
Addict Biol; 2003 Mar; 8(1):49-57. PubMed ID: 12745416
[TBL] [Abstract][Full Text] [Related]
2. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
3. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Buntwal N; Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
[TBL] [Abstract][Full Text] [Related]
5. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and cognitive effects of lofexidine and methadone coadministration: a pilot study.
Schroeder JR; Schmittner J; Bleiberg J; Epstein DH; Krantz MJ; Preston KL
Pharmacotherapy; 2007 Aug; 27(8):1111-9. PubMed ID: 17655511
[TBL] [Abstract][Full Text] [Related]
8. The use of clonidine in detoxification from opiates.
Kleber HD; Gold MS; Riordan CE
Bull Narc; 1980; 32(2):1-10. PubMed ID: 6907020
[TBL] [Abstract][Full Text] [Related]
9. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
Gish EC; Miller JL; Honey BL; Johnson PN
Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
[TBL] [Abstract][Full Text] [Related]
10. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
11. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
[TBL] [Abstract][Full Text] [Related]
12. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
Glasper A; Gossop M; de Wet C; Reed L; Bearn J
Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
[TBL] [Abstract][Full Text] [Related]
13. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
Strang J; Bearn J; Gossop M
Am J Addict; 1999; 8(4):337-48. PubMed ID: 10598217
[TBL] [Abstract][Full Text] [Related]
14. Unexpected delirium during Rapid Opioid Detoxification (ROD).
Golden SA; Sakhrani DL
J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
[TBL] [Abstract][Full Text] [Related]
15. The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome.
Bearn J; Bennett J; Martin T; Gossop M; Strang J
Addict Biol; 2001 Apr; 6(2):147-156. PubMed ID: 11341854
[TBL] [Abstract][Full Text] [Related]
16. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
Washton AM; Resnick RB; Geyer G
J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
Camarasa X; Khazaal Y; Besson J; Zullino DF
Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
[TBL] [Abstract][Full Text] [Related]
18. A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
Grüsser SM; Thalemann CN; Platz W; Gölz J; Partecke G
Biol Psychol; 2006 Mar; 71(3):231-5. PubMed ID: 16046046
[TBL] [Abstract][Full Text] [Related]
19. Opiate addiction in China: current situation and treatments.
Tang YL; Zhao D; Zhao C; Cubells JF
Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
[TBL] [Abstract][Full Text] [Related]
20. Outpatient opiate detoxification with clonidine.
Washton AM; Resnick RB
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
